BucherK, Rodriguez-BocanegraE, DauletbekovD, et al.Immune responses to retinal gene therapy using adeno-associated viral vectors—implications for treatment success and safety. Prog Retin Eye Res, 2020:100915.
2.
BottoC, RucliM, TekinsoyMD, et al.Early and late stage gene therapy interventions for inherited retinal degenerations. Prog Retin Eye Res, 2021:100975.
3.
KoponenS, KokkiE, KinnunenK, et al.Viral-vector-delivered anti-angiogenic therapies to the eye. Pharmaceutics, 2021; 13:219.
KuriharaT, WestenskowPD, BravoS, et al.Targeted deletion of Vegfa in adult mice induces vision loss. J Clin Invest, 2012; 122:4213–4217.
6.
FordKM, Saint-GeniezM, WalsheT, et al.Expression and role of VEGF in the adult retinal pigment epithelium. Invest Ophthalmol Vis Sci, 2011; 52:9478–9487.
7.
UsuiY, WestenskowPD, KuriharaT, et al.Neurovascular crosstalk between interneurons and capillaries is required for vision. J Clin Invest, 2015; 125:2335–2346.
8.
SuzukiM, OzawaY, KubotaS, et al.Neuroprotective response after photodynamic therapy: role of vascular endothelial growth factor. J Neuroinflammation, 2011; 8:176.
9.
Saint-GeniezM, MaharajAS, WalsheTE, et al.Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS One, 2008; 3:e3554.
10.
FrogerN, MatontiF, RoubeixC, et al.VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons. Sci Rep, 2020; 10:12409.
11.
Saint-GeniezM, MaldonadoAE, D'AmorePA. VEGF expression and receptor activation in the choroid during development and in the adult. Invest Ophthalmol Vis Sci, 2006; 47:3135–3142.
12.
MarnerosAG, FanJ, YokoyamaY, et al.Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol, 2005; 167:1451–1459.
13.
JinK, ZhuY, SunY, et al.Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A, 2002; 99:11946–11950.
14.
PelletierJ, RoudierE, AbrahamP, et al.VEGF-A promotes both pro-angiogenic and neurotrophic capacities for nerve recovery after compressive neuropathy in rats. Mol Neurobiol, 2015; 51:240–251.
15.
ParkHY, KimJH, ParkCK. Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model. Am J Pathol, 2014; 184:1752–1762.
16.
SeneA, Chin-YeeD, ApteRS. Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye. Trends Mol Med, 2015; 21:43–51.
17.
HaugSJ, HienDL, UludagG, et al.Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration. Am J Ophthalmol Case Rep, 2020; 18:100680.
18.
WitkinAJ, HahnP, MurrayTG, et al.Occlusive retinal vasculitis following intravitreal brolucizumab. J Vitreoretin Dis, 2020; 4:269–279.
19.
KauppinenA, PaternoJJ, BlasiakJ, et al.Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci, 2016; 73:1765–1786.
20.
TanW, ZouJ, YoshidaS, et al.The role of inflammation in age-related macular degeneration. Int J Biol Sci, 2020; 16:2989–3001.
21.
ChengSY, MalachiA, CipiJ, et al.HK2 mediated glycolytic metabolism in mouse photoreceptors is not required to cause late stage age-related macular degeneration. Biomolecules, 2021; 11:871.
22.
BhagatN, GrigorianRA, TutelaA, et al.Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol, 2009; 54:1–32.
